Jerome Dalin holds a Msc/Engineering degree in Industrial manufacturing and Biological engineering. He started his career at Sanofi Pasteur 20 years ago in vaccine process development in France and then joined our company in 2013 to manage bioprocessing sales with vaccine project coordination at a global level. From 2021 to 2022, Jerome led strategic initiatives and supported go-to-market strategies with special focus on vaccine and traditional modalities. In his current role, he’s focusing its activities on Biopharma 4.0 strategy development.
This whitepaper describes the development and use of a cost model encompassing capital, labor, materials, consumables, and other costs, which are five key parameters of manufacturing for a variety of vaccine modalities: vaccines which use inactivated and attenuated viruses, protein subunit vaccines, virus-like particles (VLP) vaccines, Viral vector vaccines, and mRNA vaccines.
The biopharmaceutical industry trends towards new product classes and smaller batch sizes drives even a greater need for…
This webinar describes the collaboration of
